We provide you with 20 years of free, institutional-grade data for CALT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CALT. Explore the full financial landscape of CALT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about CALT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Calliditas Therapeutics AB - ADR(NASDAQ:CALT) 
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a unique formulation optimized to...
Website: https://www.calliditas.se/
Founded: 2004
Full Time Employees: 23
CEO: Renée Julie Elisabet Aguiar-Lucander
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends